6McLaughlin BE, Tosone CM, Custer LM, et al. Overview of extracorporeal liver support systems and clinical results. Ann N Y Acad Sci, 1999, 875: 310-325.
7Ronco C, Tetta C, Mariano F, et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs, 2003, 27: 792-801.
8Yoshiba M, Inoue K, Sekiyama K, et al. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artif Organs, 1996, 20:1169-1172.
9Sadahiro T, Hirasawa H, Oda S, et al. Usefulness of plasma exchange plus continuous hemodiafiltration to reduce adverse effects associated with plasma exchange in patients with acute liver failure. Crit Care Med, 2001, 29: 1386-1392.
10Nakae H, Yonekawa T, Narita K, et al. Are proinflammatory cytokine concentrations reduced by plasma exchange in patients with severe acute hepatic failure? Res Commun Mol Pathol Pharmacol, 2001,109: 65-72.
